Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3547 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-05-19 (inequality.org)
The Other Corporate Restraints -
Amid the Trump administration's regulatory rollbacks, two forces continue to serve as checks on corporate misconduct: state-level regulation and private litigation.
Read more
2025-05-13 (mountainstatespotlight.org)
West Virginia Supreme Court punts Huntington-Cabell overdose case
West Virginia's Supreme Court has refused to help a federal appeals panel resolve a case that seeks to make three of the nation's largest drug distributors pay to abate the state's opioids overdose crisis.
Read more
2024-11-12 (scmagazine.com)
Millions of records from MOVEit hack released on dark web
A threat actor operating under the alias "Nam3L3ss" posted at least 25 CSV datasets on the BreachForums hacking site that contains millions of records from leading companies — data likely stolen during last year’s MOVEit transfer vulnerability case.
Read more
2022-02-25 (fiercepharma.com)
Johnson & Johnson, drug distributors finalize $26B opioid settlement as states join the landmark deal |
A large portion of the mountain of U.S. opioid lawsuits is coming to an end for four healthcare giants. | Johnson & Johnson and three major drug distributors—AmerisourceBergen, Cardinal Health and McKesson—have each decided to finalize a landmark $26 billion settlement to resolve claims that they helped fuel the opioid crisis.
Read more
2021-11-02 (aljazeera.com)
California hands pharma industry first win in US opioid case | Business and Economy News |
California counties argued that drugmakers' marketing downplayed opioids' addictive risks but judge said 'no evidence'.
Read more